Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2471-2480 of 2876 for cancer

Edit search filters
  1. Evaluating Intestinal Microbiome And Immune Function In Lymphoma

    Rochester, MN

  2. A Study Of Staging Procedures To Diagnose Malignant Pleural Mesothelioma

    Rochester, MN

  3. Analyzing Oesophago-Gastric Leaks From Diagnosis to Management

    Jacksonville, FL

  4. Image-based Mapping Of Brain Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study To Learn About How Women Metabolize And Respond To Opioids When Used For Managing Post-operative Pain

    Rochester, MN

  6. A Study For Germline Mutations Of Patients With Phyllodes Tumors Of The Breast

    Rochester, MN

  7. Establishment Of Preclinical Models From Patients With Gynecological Malignancies

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Evaluation Of A Patient-Reported Symptom Index For NMIBC

    Rochester, MN

  9. A Study of Pharmacogenomics Results and Clinical Data of Patients with Chronic Myeloid Leukemia and Lung Cancer to Assess Current and Future Therapeutic Relevance

    Rochester, MN

  10. A Study to Compare Optimal MRI Timing for Pre-surgical Planning to LINAC-based Therapy

    Rochester, MN

.

Mayo Clinic Footer